Cannabinoid Hyperemesis Syndrome (CHS): The Hidden Risk Behind Cannabis Normalization
If you’re over a certain age, you likely remember a time when cannabis was almost universally stigmatized — portrayed as a dangerous “gateway” drug, a moral corruptor, or something inherently destructive.
That perception shifted dramatically throughout the 2000s and early 2010s. Scientific research expanded. Public opinion softened. Medical cannabis programs grew. Recreational legalization followed in many jurisdictions.
As of early 2026, adult-use cannabis is legal in at least 24 U.S. states and territories. Cultural attitudes have evolved alongside policy changes. Cannabis is no longer widely seen as “the devil’s drug,” even among many who choose not to use it.
But normalization does not eliminate risk.
While cannabis has documented therapeutic uses and a relatively favorable safety profile compared to many substances, long-term heavy use can produce unexpected medical consequences. One of the most alarming — and still poorly understood — is a condition called Cannabinoid Hyperemesis Syndrome (CHS).
Colloquially, some patients call it “scromiting.”
What Is Cannabinoid Hyperemesis Syndrome (CHS)?
Cannabinoid Hyperemesis Syndrome is a medical condition associated with long-term, frequent cannabis use that results in repeated episodes of:
Severe nausea
Persistent vomiting
Intense abdominal pain
The paradox is striking.
Cannabis is widely known for its anti-nausea effects. In fact, synthetic cannabinoids are prescribed to cancer patients to treat chemotherapy-induced nausea. Yet in CHS, chronic exposure appears to reverse that effect.
Instead of suppressing nausea, it triggers uncontrollable vomiting.
The slang term “scromiting” combines screaming and vomiting, reflecting the severity of episodes experienced by some patients. Though not a clinical term, it captures the distress many sufferers describe.
How CHS Develops: Current Theories and Mechanisms
Despite growing recognition, the precise biological mechanism behind CHS remains under investigation.
What researchers do know:
CHS occurs almost exclusively in daily or near-daily cannabis users.
Symptoms typically develop after months or years of chronic use.
Many patients report using cannabis heavily for 10+ years before symptoms begin.
Not every heavy user develops CHS.
The Endocannabinoid System Hypothesis
The leading explanation involves the endocannabinoid system (ECS) — a complex signaling network that regulates:
Mood
Appetite
Pain perception
Nausea and vomiting
Gastrointestinal function
Cannabis compounds such as THC bind to cannabinoid receptors (primarily CB1 and CB2). Chronic overstimulation of these receptors may disrupt normal regulation of nausea pathways.
Over time, this dysregulation may lead to:
Altered gut motility
Abnormal stress responses
Paradoxical vomiting
Researchers also suspect that high-potency cannabis products — including concentrates, vapes, and high-THC edibles — may increase risk. However, definitive causal relationships are still being studied.
The Three Phases of CHS
CHS typically progresses through three stages.
1. Prodromal Phase
This early phase can last months or years.
Symptoms include:
Mild persistent nausea
Morning queasiness
Abdominal discomfort
Fear of vomiting
Many individuals mistakenly increase cannabis use during this stage, believing it will reduce nausea — unintentionally accelerating progression.
2. Hyperemetic Phase
This is the most severe stage and often leads to emergency care.
Symptoms include:
Intense, relentless nausea
Vomiting multiple times per hour
Severe abdominal pain
Screaming during vomiting episodes (“scromiting”)
Compulsive hot showers or baths for relief
The hot bathing behavior is particularly characteristic of CHS. Many patients report temporary relief when exposed to hot water — a phenomenon still not fully explained.
This phase can last 24–72 hours or longer.
3. Recovery Phase
If cannabis use stops completely, symptoms gradually resolve over days to weeks.
If cannabis use resumes, symptoms often return quickly — sometimes more severely.
Epidemiology: How Common Is CHS?
Estimating prevalence is difficult.
For years, CHS lacked a specific diagnostic code, making tracking inconsistent. Additionally, its symptoms overlap with other gastrointestinal disorders.
However, recent data suggest rising incidence:
Emergency department visits coded for CHS increased significantly between 2016 and 2022.
Rates rose during COVID-19 pandemic years and remained elevated.
Studies in adolescents (ages 13–21) show increasing CHS-related ER visits through 2023.
Some datasets indicate increases approaching 50% per year in certain populations.
Surveys of CHS patients report:
85% had at least one ER visit.
Nearly half required hospitalization.
These findings suggest CHS is not rare and may represent a growing public health issue tied to increased cannabis exposure and potency.
Who Is Most at Risk?
CHS has been most commonly observed among:
Daily or near-daily cannabis users
Individuals who began use during adolescence
Adults aged 18–35
Long-term high-THC product users
Some research suggests slightly higher rates among males, though cases occur across all genders.
Importantly, not all chronic users develop CHS. Genetic susceptibility may play a role, though this remains under study.
Why CHS Is Frequently Misdiagnosed
CHS mimics several other conditions:
Cyclic vomiting syndrome
Viral gastroenteritis
Food poisoning
Pancreatitis
Migraine-associated vomiting
Because of this overlap, many patients undergo extensive diagnostic testing before CHS is considered.
Consequences may include:
Repeated ER visits
CT scans and imaging
Endoscopy procedures
Increased healthcare costs
Delayed effective treatment
A careful cannabis use history is critical for accurate diagnosis.
Diagnosis: A Clinical Assessment
There is no laboratory test for CHS.
Diagnosis typically relies on:
Recurrent vomiting episodes
Long-term cannabis use history
Symptom resolution after cannabis cessation
Compulsive hot bathing behavior
In October 2025, an official clinical diagnostic code for CHS was introduced — a major advancement for tracking, insurance documentation, and research.
Treatment: What Works and What Doesn’t
One of the most frustrating aspects of CHS is poor response to standard anti-nausea medications.
Drugs such as:
Ondansetron
Promethazine
often provide limited relief.
Emergency treatment may include:
Intravenous fluids
Electrolyte correction
Pain management
Off-label use of haloperidol
Topical capsaicin cream
Hot showers frequently provide temporary symptom relief.
The Only Proven Long-Term Solution
Complete cessation of cannabis use.
All forms must stop:
Smoked
Vaped
Edibles
Concentrates
Once cannabis is discontinued, symptoms gradually resolve.
Continued use almost always leads to recurrence.
Complications of Untreated CHS
Repeated vomiting can cause:
Severe dehydration
Electrolyte imbalance
Acute kidney injury
Esophageal tears
Dental damage
While deaths are rare, untreated metabolic complications can become life-threatening.
Why CHS Is Receiving Increased Attention
Several factors explain growing awareness:
Legalization and increased access
Higher THC potency products
Improved clinician education
Reduced stigma discussing cannabis use
Introduction of diagnostic coding
Public health researchers caution against over-diagnosis, but the majority of clinical evidence supports CHS as a real and rising phenomenon.
Balancing Cannabis Benefits and Risks
Cannabis has documented medical applications:
Chronic pain
Chemotherapy-related nausea
Certain seizure disorders
Appetite stimulation
However, normalization should not obscure risks.
CHS demonstrates that even substances perceived as relatively safe can produce serious consequences when used heavily over long periods.
Conclusion: Awareness Without Alarmism
Cannabis legalization reflects evolving public values and scientific understanding.
But legalization does not equal harmlessness.
Cannabinoid Hyperemesis Syndrome represents a paradoxical and often shocking complication of chronic cannabis use — one that can severely impact health and quality of life.
Education is key.
Recognizing:
Persistent unexplained vomiting
Chronic daily cannabis use
Relief with hot showers
can prevent years of suffering.
The only definitive treatment is cessation.
If you or someone you know experiences recurrent vomiting associated with long-term cannabis use, consult a qualified healthcare provider.
Early recognition reduces unnecessary testing, prevents complications, and improves outcomes.
As with any substance — legal or not — informed use, moderation, and awareness remain essential.
0 commentaires:
Enregistrer un commentaire